Western Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Western Europe Analysis

Industry Trend Analysis - Takeda Investment Highlights Growing Confidence In TiGenix - MAR 2017

Takeda's equity investment in TiGenix, coinciding with a recent US IPO, highlights a growing confidence in TiGenix and its lead product, Cx601, for treating complex perianal fistulas in Crohn's disease. Although Cx601 has yet to be commercialised, and TiGenix has yet to make a profit, development of the drug is progressing smoothly. Should Cx601 be approved and launched in the US and the EU, it...

READ FULL ARTICLE...

Industry Trend Analysis - Psoriasis Indication Will Reinforce Cimzia's Worth To UCB - FEB 2017

In seeking to expand the number of conditions Cimzia is indicated for, UCB is following a well-trodden path in the autoimmune sphere. A successful indication for psoriasis would prove to be highly beneficial. The condition affects nearly 3% of the world's population, or around 125mn. Cimzia is already a cornerstone drug for UCB, but with key patents for Cimzia expiring in 2024, UCB will be keen...

READ FULL ARTICLE...